Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Urinary Bladder01:23

Urinary Bladder

4.1K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
4.1K
Imaging Studies VI: Voiding Cystourethrography and Cystography01:22

Imaging Studies VI: Voiding Cystourethrography and Cystography

3.2K
Voiding Cystourethrography (VCUG) and Cystography are specialized radiographic procedures used to examine the structure and function of the bladder and urethra.Voiding Cystourethrography (VCUG)A Voiding Cystourethrogram (VCUG) is a diagnostic imaging procedure that assesses the anatomy and function of the lower urinary tract. It focuses on the bladder, bladder neck, and urethra, helping detect abnormalities such as vesicoureteral reflux (VUR)—the backward or reverse flow of urine into the...
3.2K
Anatomy of the Genitourinary System II: Bladder and Urethra01:19

Anatomy of the Genitourinary System II: Bladder and Urethra

2.4K
The lower urinary system consists of the urinary bladder and urethra, which are essential in storing and expelling urine from the body. Together with the internal and external sphincters, these structures work together to regulate urination effectively.Anatomy of the BladderThe urinary bladder is a muscular, stretchable organ behind the pubic bone and in front of the rectum. In females, the bladder is positioned anterior to the vagina and inferior to the uterus, while in males, it is located...
2.4K
Nursing Assessment of the Genitourinary System II: Inspection and Palpation01:26

Nursing Assessment of the Genitourinary System II: Inspection and Palpation

1.2K
The nursing assessment of the genitourinary (GU) system involves a systematic inspection and palpation to identify abnormalities in the kidneys, bladder, and surrounding structures.InspectionMouth: Inspect for signs of kidney dysfunction, such as stomatitis (inflammation of the mouth) and ammonia breath, which may occur in advanced kidney disease due to the buildup of urea, breaking down into ammonia.Skin: Check for pallor, which could indicate anemia caused by kidney disease. Look for...
1.2K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.4K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.4K
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

562
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
562

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Bladder Preservation After Neoadjuvant Therapy for Muscle-invasive Bladder Cancer in the Current Era: Myth and Reality.

European urology focus·2025
Same author

Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group.

European urology oncology·2025
Same author

Revisiting Neoadjuvant Chemotherapy in Cisplatin-eligible Muscle-invasive Bladder Cancer.

European urology oncology·2025
Same author

Development and International Evaluation of an Artificial Intelligence-based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non-muscle-invasive Bladder Cancer.

European urology·2025
Same author

Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey.

The oncologist·2025
Same author

Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the Bladder.

European urology·2025

関連する実験動画

Updated: Mar 18, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.2K

膀 がん

Ashish M Kamat1, Noah M Hahn2, Jason A Efstathiou3

  • 1Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Lancet (London, England)
|June 28, 2016
PubMed
まとめ
この要約は機械生成です。

膀がんの早期診断と 適切な治療は 膀がんの管理に不可欠です 治療戦略は,筋肉侵襲性でない腫瘍の腸内療法から,筋肉侵襲性疾患の急性半球切除術または膀を節約するオプションまで様々であり,進行段階では免疫療法が出現しています.

さらに関連する動画

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.9K
An Orthotopic Model of Murine Bladder Cancer
09:07

An Orthotopic Model of Murine Bladder Cancer

Published on: February 6, 2011

16.6K

関連する実験動画

Last Updated: Mar 18, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.2K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.9K
An Orthotopic Model of Murine Bladder Cancer
09:07

An Orthotopic Model of Murine Bladder Cancer

Published on: February 6, 2011

16.6K

科学分野:

  • 泌尿器科
  • 腫瘍学
  • 医学 研究

背景:

  • 膀がんは,効果的に管理されない場合,著しい罹病率と死亡率を示します.
  • ヘマチュリアは重要な症状であり,迅速な診断と個別化された治療の必要性を強調しています.
  • 最適な治療とフォローアップは 患者の成功のために不可欠です

研究 の 目的:

  • 膀がんの現在の診断と治療のパラダイムを概説する.
  • 癌の段階に基づく 個別化された治療戦略の重要性を強調する.
  • 最近の遺伝学的な発見の影響を議論する.

主な方法:

  • 非筋肉侵襲性膀がん (NMIBC) の確立された治療プロトコルのレビュー
  • 筋肉侵襲性膀がん (MIBC) の多式治療法の分析
  • 進行した膀がんに対する全身化学療法と免疫療法の評価
  • 膀を節約するトリモダリティ治療の選択肢の検討

主要な成果:

  • 腫瘍を完全に切除し,その後,腸内免疫療法 (BCGワクチン) または化学療法を行うのがNMIBCの標準です.
  • ネオアジュバント化学療法による急性半球切除はMIBCの最良の治療の可能性を提供します.
  • 膀を節約するトリモダリティ治療は,選択されたMIBC患者にとって有効な選択肢です.
  • システム化学療法は,進行した病気の主要な治療法であり,免疫療法は救済の選択肢です.

結論:

  • 膀がんの治療には 腹腔内療法から 徹底的な手術や化学療法まで 個別化された治療法が不可欠です
  • 遺伝子サブタイプに関する新しい研究は,治療の選択をさらに洗練し,患者の反応を改善する可能性があります.
  • 継続的なフォローアップと,病気の段階と患者の要因に基づく治療の適応は極めて重要です.